Linezox, is a synthetic novel antibacterial agent in the new class of antibiotics called Oxazolidinones. This new class has a unique chemical structure and a novel mechanism of action. Therefore, cross-resistance between Anzolid and other classes of antibiotics is unlikely.
Clinical and microbiological findings demonstrate that Anzolid has clinical utility and is effective and safe for the treatment of certain infections caused by indicated aerobic gram +ve bacteria.
|
- Nosocomial pneumonia
- Community acquired pneumonia
- Complicated skin & skin structure infections
- Uncomplicated skin & skin structure infections
- Vancomycin-resistant enterococci infections
- Bacteremia/Septicemia
|
|
